NEWTON, Mass., Oct. 24 /PRNewswire-FirstCall/ -- Clinical Data, Inc. today announced that Drew Fromkin, Executive Vice President and Chief Marketing Officer of Clinical Data, will present on behalf of the company at the C.E. Unterberg, Towbin Life Sciences Conference on Tuesday, October 25, 2005 at 9:30am, eastern, in New York City.
About Clinical Data, Inc.
Clinical Data, Inc. is a worldwide leader in developing and commercializing pharmacogenomics and clinical diagnostics to improve patient care. The Company's genomic services are marketed to the pharmaceutical, biotech, diagnostic, academic and agricultural marketplaces. The Company is utilizing pharmacogenomics to develop molecular diagnostics and more efficacious therapeutics by finding genetic markers to guide drug development and utilization. Its diagnostic and instrumentation business has a market focus on the physician office, hospital and small to medium sized laboratory segments.
Clinical Data, Inc.CONTACT: Mark D. Shooman, Sr. Vice President & Chief Financial Officer,+1-617-527-9933 Ext. 41
Web site: http://www.genaissance.com/
